Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury

Tanta University

Status

Completed

Conditions

S100B

Brain Injury

Neutrophils/Lymphocytes Ratio

Prediction

Treatments

Diagnostic Test: S100B Protein

Diagnostic Test: Neutrophils to Lymphocytes ratio

Study type

Observational

Funder types

Other

Identifiers

NCT07093723

36264PR392/10/23

Details and patient eligibility

About

The study aimed to evaluate the role of Protein S100B versus the neutrophil-to-lymphocyte ratio (NLR) as an early predictor biomarker and the value of amplitude-integrated electroencephalography (aEEG) as an early predictor and prognostic method for neonatal brain injury susceptibility and severity.

Full description

The most prevalent types of newborn brain injury (NBI) are intraventricular haemorrhage (IVH), periventricular leukomalacia (PVL), and hypoxic-ischemic encephalopathy (HIE), which can affect neonates born at any gestational age (GA).

Amplitude-integrated EEG (aEEG) is another early predictor and prognostic technique for Neonatal Brain Injury. Electrophysiological brain activity, as measured by aEEG, is a well-established method for giving information on the functional and metabolic status of the brain and the incidence of epileptic seizure episodes.

S100B belongs to the S100 family. Because it is soluble in a 100% saturated solution of ammonium sulfate, it was designated "S100." S100 protein is a calcium-binding cytosolic protein with a molecular weight of 21 kDa comprised of 2 monomers, which are found in a variety of cells and are primarily concentrated in the glial cells of the CNS. Due to its molecular weight, peripheral blood will detect only S100B.

The neutrophil-to-lymphocyte ratio (NLR) reflects changes in neutrophil and lymphocyte levels, which is an indication of inflammation.

Enrollment

60 patients

Sex

All

Ages

28 to 36 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria